The filling of sterile drugs into prefilled syringes (and other primary drug containers) is considered to be one of the most crucial steps in the pharmaceutical production process. Proper fill / finish operations, carried out under aseptic conditions, is a necessity for not only maintaining pharmacological efficacy and quality, but also ensuring end user safety. The prefilled syringe filling operation is considered complex as it requires close monitoring of both the syringe fill volume as well as the headspace between the liquid in the syringe and the bottom of the plunger. Additionally, the rise in complexity of small molecule APIs and the increasing diversity of biologic drugs have also contributed towards the demand for advanced aseptic fill / finish operations. A number of small-sized companies and some large companies have outsourced their fill / finish operations to contract service providers. According to the 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, biomanufacturers have been shown to outsource over 30% of their fill / finish operations. With the increase in the demand for prefilled syringes, along with the growing complexity of fill / finish processes, the outsourcing of these operations is likely to increase further in the future.Cur rently, over 100 companies are actively providing fill / finish services for prefilled syringes.
To request sample pages, please visit : https://www.rootsanalysis.com/reports/301/request-sample.html
Majority of these service providers (48%) are large companies (more than 500 employees), followed by 40% mid-sized companies (51-500 employees). Further, there are 12 small-sized companies (less than 50 employees) that offer fill / finish services for prefilled syringes. Examples of such companies include (in alphabetical order) Akron Biotech, Alanza, Bryllan, Hisun Pharmaceuticals USA, KP Pharmaceutical Technology and VxP Biologics.
Fill-Finish – The filling of sterile drugs into prefilled syringes (and other primary drug containers) is considered to be one of the most crucial steps in the pharmaceutical production process.
Further, the market landscape features the presence of well-established players in the domain, most of which claim to operate at various scales of operation and are located in different geographies. Among the players that were established before 2001, majority (51) of the players are capable of handling small molecules and within these players, 31 service providers are large companies followed by mid-sized (18) service providers.
Aseptic Filling – The ‘Prefilled Syringe Fill / Finish Service Providers, 2020-2030’ report features an extensive study of the current market landscape and future opportunities for contract service providers offering fill finish services for prefilled syringes.
Majority (51%) of the service providers offer fill / finish services at both clinical and commercial scales of operation. It is worth highlighting that, most of the service providers are headquartered in Europe (34%) followed by North America (33%). Moreover, in order to acquire competencies across the supply chain and cater to the evolving needs of clients, companies offering services across different scales of operation have established presence in various geographies by establishing fill / finish facilities at varied locations. Around 40% of the service providers have fill / finish facilities in Europe with Germany and Italy as the key geographies. Further, 32% players have fill / finish facilities in North America. Examples of players that have more than one prefilled syringe fill / finish facilities include (in alphabetic order) AbbVie Contract Manufacturing, Ajinomoto Bio-Pharma Services, Boehringer Ingelheim BioXcellence, Catalent Biologics, LSNE Contract Manufacturing and Vetter Pharma.
Prefilled Syringe Packaging – Currently, over 100 companies are actively providing fill / finish services for prefilled syringes. In order to cope up with the current and future market demand, service providers are actively investing in expanding their existing infrastructure and capabilities; companies are also expanding their client reach through service agreements in the past few years. Given that around 55% of drug candidates in the global R&D pipeline are injectables, the opportunities for prefilled syringe developers / manufacturers and affiliated service providers is anticipated to continue to grow over the next decade.
Given that multiple biologicals are about to go off-patent, a wave of biosimilars are soon anticipated to enter the market. We believe that this is likely to create significant opportunities within the developing markets of the Asia Pacific region, specifically in China and India. Many companies are setting up facilities in these regions to serve the domestic and lesser-regulated international markets. In addition, the scientific acumen, technical expertise and production capacity of companies based in the region have grown significantly over the past decade. It is also worth mentioning that a number of companies that are based in the developed regions in the west have built wholly / partially owned facilities in this region. Even the indigenous players, currently offer services and solutions that are considered to be at par with world-class biopharmaceutical CMOs and CDMOs. Low production costs coupled to superior infrastructure and availability of skilled labor makes outsourcing to Asia-Pacific an attractive option. Currently, 30% of the prefilled syringe fill / finish service providers have fill / finish facilities in Asia-Pacific region. It is worth highlighting that within Asia-Pacific region, majority of the service providers have facilities located in India (18).
For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html
Other recent offerings:
- Sustainable, Biodegradable and Eco-Friendly Packaging Providers Market: Industry Trends and Global Forecast, 2021-2035
- Novel Drug Reconstitution Systems Market: Industry Trends and Global Forecast, 2021-2030
- Global Pharmaceutical Vials Market: Industry Trends and Global Forecasts, 2021-2030
- Cell Therapy Packaging Products and Services Market: Industry Trends and Global Forecast, 2021-2030
- Pre-Sterilized / Ready-to-Use Primary Packaging Market: Industry Trends and Global Forecast, 2021-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook – https://www.facebook.com/RootsAnalysis
LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter – https://twitter.com/RootsAnalysis
Medium – https://medium.com/@RootsAnalysis
Pinterest – https://in.pinterest.com/RootsanalysisPin/_saved/
Quora – https://rootsanalysisinsights.quora.com/
